Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans-Reference-Cited by-同舟云学术

Metabolism And Excretion of the Dipeptidyl Peptidase 4 Inhibitor [14C]Sitagliptin in Humans

Published:2007-01-12 Issue:4 Volume:35 Page:533-538
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Vincent Stella H.,Reed James R.,Bergman Arthur J.,Elmore Charles S.,Zhu Bing,Xu Shiyao,Ebel David,Larson Patrick,Zeng Wei,Chen Li,Dilzer Stacy,Lasseter Kenneth,Gottesdiener Keith,Wagner John A.,Herman Gary A.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference15 articles.

1. Disposition of the Dipeptidyl Peptidase 4 Inhibitor Sitagliptin in Rats and Dogs

2. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

3. Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes

4. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy;Frontiers in Pharmacology;2024-06-18

2. Sitagliptin: the fixed combination of the first dipeptidyl peptidase 4 inhibitor and metformin;Meditsinskiy sovet = Medical Council;2023-08-19

3. Metabolism and Chemical Degradation of New Antidiabetic Drugs (Part II): A Review of Analytical Approaches for Analysis of Gliptins;Biomedicines;2023-07-11

4. Chemoproteomic identification of a DPP4 homolog in Bacteroides thetaiotaomicron;Nature Chemical Biology;2023-06-22

5. Pharmacokinetics and relative bioavailability of sitagliptin hydrochloride and sitagliptin phosphate tablets formulations: a randomized, open-label, crossover study in healthy male volunteers;Generics and Biosimilars Initiative Journal;2023-04-15